Home/Filings/4/0001493152-23-029733
4//SEC Filing

Chapman Christopher C JR 4

Accession 0001493152-23-029733

CIK 0001904286other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 6:00 PM ET

Size

5.7 KB

Accession

0001493152-23-029733

Insider Transaction Report

Form 4
Period: 2023-08-17
Chapman Christopher C JR
DirectorExecutive Chairman
Transactions
  • Award

    Stock Options

    2023-08-17+50,00050,000 total
    Exercise: $6.50Exp: 2033-08-17Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023.
  • [F2]The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vested in full on August 17,2023.

Documents

1 file

Issuer

MIRA PHARMACEUTICALS, INC.

CIK 0001904286

Entity typeother

Related Parties

1
  • filerCIK 0001340428

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 6:00 PM ET
Size
5.7 KB